Two Sigma Investments, LP Fulcrum Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 272,107 shares of FULC stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

272,107

Previous 509,688 46.61%

Holding current value

$1.24 Million

Previous $3.16 Million 69.27%

% of portfolio

0.0%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.18 - $9.74 $755,507 - $2.31 Million	-237,581 Reduced 46.61%	272,107 $971,000
Q2 2024 Aug 14, 2024	BUY	$5.98 - $9.31 $2 Million - $3.11 Million	334,464 Added 190.88%	509,688 $3.16 Million
Q1 2024 May 15, 2024	SELL	$6.7 - $12.0 $579,737 - $1.04 Million	-86,528 Reduced 33.06%	175,224 $1.65 Million
Q4 2023 Feb 14, 2024	SELL	$3.18 - $6.86 $955,179 - $2.06 Million	-300,371 Reduced 53.44%	261,752 $1.77 Million
Q3 2023 Nov 14, 2023	SELL	$3.25 - $6.08 $51,164 - $95,717	-15,743 Reduced 2.72%	562,123 $2.5 Million
Q2 2023 Aug 14, 2023	SELL	$2.26 - $3.8 $162,593 - $273,387	-71,944 Reduced 11.07%	577,866 $1.91 Million
Q1 2023 May 15, 2023	BUY	$2.83 - $13.99 $1.46 Million - $7.23 Million	516,791 Added 388.51%	649,810 $1.85 Million
Q4 2022 Feb 14, 2023	BUY	$5.01 - $8.35 $666,425 - $1.11 Million	133,019 New	133,019 $968,000
Q2 2022 Aug 15, 2022	BUY	$4.2 - $24.0 $831,024 - $4.75 Million	197,863 Added 1170.79%	214,763 $1.05 Million
Q1 2022 May 16, 2022	SELL	$9.96 - $23.65 $5.02 Million - $11.9 Million	-504,090 Reduced 96.76%	16,900 $400,000
Q4 2021 Feb 14, 2022	SELL	$14.0 - $28.44 $1.56 Million - $3.17 Million	-111,549 Reduced 17.64%	520,990 $9.22 Million
Q3 2021 Nov 15, 2021	BUY	$7.28 - $30.97 $4.49 Million - $19.1 Million	616,928 Added 3951.88%	632,539 $17.8 Million
Q2 2021 Aug 16, 2021	BUY	$8.09 - $12.0 $13,202 - $19,584	1,632 Added 11.67%	15,611 $164,000
Q1 2021 May 17, 2021	SELL	$10.94 - $15.32 $149,527 - $209,393	-13,668 Reduced 49.44%	13,979 $165,000
Q4 2020 Feb 16, 2021	BUY	$7.84 - $13.4 $126,592 - $216,369	16,147 Added 140.41%	27,647 $324,000
Q3 2020 Nov 16, 2020	BUY	$7.22 - $20.7 $83,030 - $238,050	11,500 New	11,500 $91,000

Others Institutions Holding FULC

# of Institutions

150

Shares Held

52.2M

Call Options Held

6.91M

Put Options Held

1.9M

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $237M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Fulcrum Therapeutics, Inc. Transaction History